These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Broad Institute wins bitter battle over CRISPR patents. Ledford H Nature; 2017 Feb; 542(7642):401. PubMed ID: 28230140 [No Abstract] [Full Text] [Related]
4. Use the patent system to regulate gene editing. Parthasarathy S Nature; 2018 Oct; 562(7728):486-488. PubMed ID: 30353159 [No Abstract] [Full Text] [Related]
5. Waive CRISPR patents to meet food needs in low-income countries. van der Oost J; Fresco LO Nature; 2021 Sep; 597(7875):178. PubMed ID: 34489579 [No Abstract] [Full Text] [Related]
6. CRISPR heavyweights battle in US patent court. Reardon S Nature; 2016 Dec; 540(7633):326-327. PubMed ID: 27974781 [No Abstract] [Full Text] [Related]
8. Racing for academic glory and patents: Lessons from CRISPR. Rai AK; Cook-Deegan R Science; 2017 Nov; 358(6365):874-876. PubMed ID: 29146800 [No Abstract] [Full Text] [Related]
10. Intellectual property education exemplified by the patents on the CRISPR/Cas9 system. Fan X; Liao G; Xie J Yi Chuan; 2014 Dec; 36(12):1269-73. PubMed ID: 25487273 [TBL] [Abstract][Full Text] [Related]
11. The CRISPR Patent Ruling and Implications for Medicine. Paradise J JAMA; 2023 Feb; 329(6):461-462. PubMed ID: 36637817 [TBL] [Abstract][Full Text] [Related]
12. The morality and ethics governing CRISPR-Cas9 patents in China. Peng Y Nat Biotechnol; 2016 Jun; 34(6):616-8. PubMed ID: 27281418 [No Abstract] [Full Text] [Related]
13. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges]. Bellver Capella V Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196 [TBL] [Abstract][Full Text] [Related]
14. Genome-editing technologies and patent landscape overview. Benahmed-Miniuk F; Kresz M; Kanaujiya JK; Southgate CD Pharm Pat Anal; 2017 May; 6(3):115-134. PubMed ID: 28534435 [TBL] [Abstract][Full Text] [Related]